The IHU variant has been reported just in France and not spotted in any other country or labelled a variant under investigation by the World Health Organization (WHO). It was first discovered in mid-November and is linked to travel to Cameroon in Africa.
The variant is a sub-lineage of the B.1.640 and its discovery was announced by researchers from Méditerranée Infection in Marseille, part of France’s Instituts hospitalo-universitaires (IHU, or University Hospital Institutes) - hence the name. It has been classified as B.1.640.2.
https://www.newsnationnow.com/health/coronavirus/vaccine/covaxin-india-covid-vaccine/
What is Covaxin, the COVID vaccine not approved in the US?
Covaxin takes a more traditional approach. It’s made by using a disabled form of the COVID-19 virus to stimulate the immune system.